1
|
Baukova A, Bogun A, Sushkova S, Minkina T, Mandzhieva S, Alliluev I, Jatav HS, Kalinitchenko V, Rajput VD, Delegan Y. New Insights into Pseudomonas spp.-Produced Antibiotics: Genetic Regulation of Biosynthesis and Implementation in Biotechnology. Antibiotics (Basel) 2024; 13:597. [PMID: 39061279 PMCID: PMC11273644 DOI: 10.3390/antibiotics13070597] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 06/20/2024] [Accepted: 06/25/2024] [Indexed: 07/28/2024] Open
Abstract
Pseudomonas bacteria are renowned for their remarkable capacity to synthesize antibiotics, namely mupirocin, gluconic acid, pyrrolnitrin, and 2,4-diacetylphloroglucinol (DAPG). While these substances are extensively employed in agricultural biotechnology to safeguard plants against harmful bacteria and fungi, their potential for human medicine and healthcare remains highly promising for common science. However, the challenge of obtaining stable producers that yield higher quantities of these antibiotics continues to be a pertinent concern in modern biotechnology. Although the interest in antibiotics of Pseudomonas bacteria has persisted over the past century, many uncertainties still surround the regulation of the biosynthetic pathways of these compounds. Thus, the present review comprehensively studies the genetic organization and regulation of the biosynthesis of these antibiotics and provides a comprehensive summary of the genetic organization of antibiotic biosynthesis pathways in pseudomonas strains, appealing to both molecular biologists and biotechnologists. In addition, attention is also paid to the application of antibiotics in plant protection.
Collapse
Affiliation(s)
- Alexandra Baukova
- Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center “Pushchino Scientific Center for Biological Research of Russian Academy of Sciences” (FRC PSCBR RAS), 142290 Pushchino, Moscow Region, Russia; (A.B.); (A.B.)
- Pushchino Branch of Federal State Budgetary Educational Institution of Higher Education “Russian Biotechnology University (ROSBIOTECH)”, 142290 Pushchino, Moscow Region, Russia
| | - Alexander Bogun
- Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center “Pushchino Scientific Center for Biological Research of Russian Academy of Sciences” (FRC PSCBR RAS), 142290 Pushchino, Moscow Region, Russia; (A.B.); (A.B.)
| | - Svetlana Sushkova
- Academy of Biology and Biotechnology behalf D.I. Ivanovskyi, Southern Federal University, 344006 Rostov-on-Don, Russia; (S.S.); (T.M.); (S.M.); (I.A.); (V.D.R.)
| | - Tatiana Minkina
- Academy of Biology and Biotechnology behalf D.I. Ivanovskyi, Southern Federal University, 344006 Rostov-on-Don, Russia; (S.S.); (T.M.); (S.M.); (I.A.); (V.D.R.)
| | - Saglara Mandzhieva
- Academy of Biology and Biotechnology behalf D.I. Ivanovskyi, Southern Federal University, 344006 Rostov-on-Don, Russia; (S.S.); (T.M.); (S.M.); (I.A.); (V.D.R.)
| | - Ilya Alliluev
- Academy of Biology and Biotechnology behalf D.I. Ivanovskyi, Southern Federal University, 344006 Rostov-on-Don, Russia; (S.S.); (T.M.); (S.M.); (I.A.); (V.D.R.)
| | - Hanuman Singh Jatav
- Soil Science & Agricultural Chemistry, S.K.N. Agriculture University-Jobner, Jaipur 303329, Rajasthan, India;
| | - Valery Kalinitchenko
- Institute of Fertility of Soils of South Russia, 346493 Persianovka, Rostov Region, Russia;
- All-Russian Research Institute for Phytopathology of the Russian Academy of Sciences, Institute St., 5, 143050 Big Vyazyomy, Moscow Region, Russia
| | - Vishnu D. Rajput
- Academy of Biology and Biotechnology behalf D.I. Ivanovskyi, Southern Federal University, 344006 Rostov-on-Don, Russia; (S.S.); (T.M.); (S.M.); (I.A.); (V.D.R.)
| | - Yanina Delegan
- Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center “Pushchino Scientific Center for Biological Research of Russian Academy of Sciences” (FRC PSCBR RAS), 142290 Pushchino, Moscow Region, Russia; (A.B.); (A.B.)
- Academy of Biology and Biotechnology behalf D.I. Ivanovskyi, Southern Federal University, 344006 Rostov-on-Don, Russia; (S.S.); (T.M.); (S.M.); (I.A.); (V.D.R.)
| |
Collapse
|
2
|
Zivkovic I, Gruic-Sovulj I. Exploring mechanisms of mupirocin resistance and hyper-resistance. Biochem Soc Trans 2024; 52:1109-1120. [PMID: 38884776 DOI: 10.1042/bst20230581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Revised: 06/03/2024] [Accepted: 06/04/2024] [Indexed: 06/18/2024]
Abstract
Mupirocin is a broad-spectrum antibiotic that acts predominantly against Gram-positive bacteria. It is produced by Pseudomonas fluorescens NCIMB 10586 and has been clinically used to treat primary and secondary skin infections and to eradicate nasal colonisation of methicillin-resistant Staphylococcus aureus strains. Mupirocin inhibits protein synthesis by blocking the active site of isoleucyl-tRNA synthetase (IleRS), which prevents the enzyme from binding isoleucine and ATP for Ile-tRNAIle synthesis. Two types of IleRS are found in bacteria - while IleRS1 is susceptible to mupirocin inhibition, IleRS2 provides resistance to cells. These two types belong to distinct evolutionary clades which likely emerged from an early gene duplication in bacteria. Resistance in IleRS2 is based on the loss of interactions that govern mupirocin binding to IleRS1, such as hydrogen bonding to the carboxylate moiety of mupirocin. IleRS2 enzymes with Ki in the millimolar range have recently been discovered. These hyper-resistant IleRS2 variants surprisingly have a non-canonical version of the catalytic motif, which serves as a signature motif of class I aminoacyl-tRNA synthetases to which IleRS belongs. The non-canonical motif, in which the 1st and 3rd positions are swapped, is key for hyper-resistance and can be accommodated without abolishing enzyme activity in IleRS2 but not in IleRS1. Clinical use of mupirocin led to the emergence of resistance in S. aureus. Low-level resistance arises by mutations of the housekeeping IleRS1, while high-level resistance develops by the acquisition of the resistant IleRS2 on a plasmid. There is no evidence that hyper-resistant variants have been found in clinical isolates.
Collapse
Affiliation(s)
- Igor Zivkovic
- Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia
| | - Ita Gruic-Sovulj
- Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia
| |
Collapse
|
3
|
Nakov N, Brezovska K, Karchev V, Acevska J, Dimitrovska A. Chromatographic and Surfactant Based Potentiometric Determination of Aqueous Dissociation Constant of Mupirocin. CURR ANAL CHEM 2020. [DOI: 10.2174/1573411014666180704125016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
The available data concerning aqueous dissociation constant of mupirocin
(sparingly soluble drug) are scarce. In this study, chromatographic, surfactant based potentiometric
concept and spectrophotometric method were used for determination of the aqueous pKa value of
mupirocin.
Methods:
Different approaches were used for estimation of the aqueous pKa value from the apparent
pKa values obtained at four ACN concentrations, ranging from 22% to 30%. The potentiometric determination
of the pKa value of mupirocin was performed using different concentration of Tween 80 as
a surfactant.
Results:
The aqueous pKa value of mupirocin, determined for the first time by reverse-phase liquid
chromatography method, was found to be 4.76. The obtained value was confirmed by potentiometric
method (4.85). It was found that Tween 80 increases the pKa values. The linear relationship between
the apparent pKa values and the surfactant concentrations was used as an approach for estimation
of the aqueous pKa value. Both methods gave similar values for aqueous pKa
which correspond
with the theoretically obtained pKa value (4.88) using Pallas computer program. It was found that
mupirocin gives pH-indipendent spectra, thus spectrophotometric method is not applicable for determination
of pKa of this compound.
Conclusion:
This comprehensive approach used for the pKa determination enable us to obtained reliable
results for the aqueous pKa value of mupirocin. The linear relationship between the pKa values and
the nonionic surfactant concentrations could be used as a reliable and simple approach for determination
of aqueous pKa value of sparingly soluble drugs.
Collapse
Affiliation(s)
- Natalija Nakov
- Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Un. “SS. Cyril and Methodius”, Skopje, 1000, Macedonia, the Former Yugoslav Republic of
| | - Katerina Brezovska
- Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Un. “SS. Cyril and Methodius”, Skopje, 1000, Macedonia, the Former Yugoslav Republic of
| | - Vasil Karchev
- Center for Drug Quality Control, Faculty of Pharmacy, Un. “SS. Cyril and Methodius”, Skopje, 1000, Macedonia, the Former Yugoslav Republic of
| | - Jelena Acevska
- Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Un. “SS. Cyril and Methodius”, Skopje, 1000, Macedonia, the Former Yugoslav Republic of
| | - Aneta Dimitrovska
- Institute of Applied Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy, Un. “SS. Cyril and Methodius”, Skopje, 1000, Macedonia, the Former Yugoslav Republic of
| |
Collapse
|
4
|
Tucaliuc A, Blaga AC, Galaction AI, Cascaval D. Mupirocin: applications and production. Biotechnol Lett 2019; 41:495-502. [PMID: 30927135 DOI: 10.1007/s10529-019-02670-w] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Accepted: 03/27/2019] [Indexed: 12/30/2022]
Abstract
Mupirocin is an antibiotic from monocarboxylic acid class used as antibacterial agent against methicillin-resistant Staphylococcus aureus (MRSA) and can be obtained as a mixture of four pseudomonic acids by Pseudomonas fluorescens biosynthesis. Nowadays improving antibiotics occupies an important place in the pharmaceutical industry as more and more resistant microorganisms are developing. Mupirocin is used to control the MRSA outbreaks, for infections of soft tissue or skin and for nasal decolonization. Due to its wide use without prescription, the microorganism's resistance to Mupirocin increased from up to 81%, thus becoming imperative its control or improvement. As the biotechnological production of Mupirocin has not been previously reviewed, in the present paper we summarize some consideration on the biochemical process for the production of pseudomonic acids (submerged fermentation and product recovery). Different strains of Pseudomonas, different culture medium and different conditions for the fermentation were analysed related to the antibiotics yield and the product recovery step is analysed in relation to the final purity. However, many challenges have to be overcome in order to obtain pseudomonic acid new versions with better properties related to antibacterial activity.
Collapse
Affiliation(s)
- Alexandra Tucaliuc
- Faculty of Chemical Engineering and Environmental Protection "Cristofor Simionescu", "Gheorghe Asachi" Technical University of Iasi, Iasi, Romania
| | - Alexandra Cristina Blaga
- Faculty of Chemical Engineering and Environmental Protection "Cristofor Simionescu", "Gheorghe Asachi" Technical University of Iasi, Iasi, Romania.
| | - Anca Irina Galaction
- Faculty of Medical Bioengineering, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania
| | - Dan Cascaval
- Faculty of Chemical Engineering and Environmental Protection "Cristofor Simionescu", "Gheorghe Asachi" Technical University of Iasi, Iasi, Romania
| |
Collapse
|
5
|
Matthijs S, Vander Wauven C, Cornu B, Ye L, Cornelis P, Thomas CM, Ongena M. Antimicrobial properties of Pseudomonas strains producing the antibiotic mupirocin. Res Microbiol 2014; 165:695-704. [PMID: 25303834 DOI: 10.1016/j.resmic.2014.09.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2014] [Revised: 09/17/2014] [Accepted: 09/29/2014] [Indexed: 11/19/2022]
Abstract
Mupirocin is a polyketide antibiotic with broad antibacterial activity. It was isolated and characterized about 40 years ago from Pseudomonas fluorescens NCIMB 10586. To study the phylogenetic distribution of mupirocin producing strains in the genus Pseudomonas a large collection of Pseudomonas strains of worldwide origin, consisting of 117 Pseudomonas type strains and 461 strains isolated from different biological origins, was screened by PCR for the mmpD gene of the mupirocin gene cluster. Five mmpD(+) strains from different geographic and biological origin were identified. They all produced mupirocin and were strongly antagonistic against Staphylococcus aureus. Phylogenetic analysis showed that mupirocin production is limited to a single species. Inactivation of mupirocin production leads to complete loss of in vitro antagonism against S. aureus, except on certain iron-reduced media where the siderophore pyoverdine is responsible for the in vitro antagonism of a mupirocin-negative mutant. In addition to mupirocin some of the strains produced lipopeptides of the massetolide group. These lipopeptides do not play a role in the observed in vitro antagonism of the mupirocin producing strains against S. aureus.
Collapse
Affiliation(s)
- Sandra Matthijs
- Institut de Recherches Microbiologiques - Wiame, Campus du CERIA, 1 avenue Emile Gryson, bât 4B, B-1070 Bruxelles, Belgium.
| | - Corinne Vander Wauven
- Institut de Recherches Microbiologiques - Wiame, Campus du CERIA, 1 avenue Emile Gryson, bât 4B, B-1070 Bruxelles, Belgium.
| | - Bertrand Cornu
- Institut de Recherches Microbiologiques - Wiame, Campus du CERIA, 1 avenue Emile Gryson, bât 4B, B-1070 Bruxelles, Belgium.
| | - Lumeng Ye
- Department of Bioengineering Sciences, Research Group of Microbiology and Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel, Brussels, Belgium.
| | - Pierre Cornelis
- Department of Bioengineering Sciences, Research Group of Microbiology and Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel, Brussels, Belgium.
| | - Christopher M Thomas
- School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
| | - Marc Ongena
- Walloon Center for Industrial Biology, University of Liège, Gembloux Agro-Bio Tech, Gembloux, Belgium.
| |
Collapse
|
6
|
Agarwal V, Nair SK. Aminoacyl tRNA synthetases as targets for antibiotic development. MEDCHEMCOMM 2012. [DOI: 10.1039/c2md20032e] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
7
|
Abstract
Mupirocin, a polyketide antibiotic produced by Pseudomonas fluorescens, is used to control the carriage of methicillin-resistant Staphylococcus aureus on skin and in nasal passages as well as for various skin infections. Low-level resistance to the antibiotic arises by mutation of the mupirocin target, isoleucyl-tRNA synthetase, whereas high-level resistance is due to the presence of an isoleucyl-tRNA synthetase with many similarities to eukaryotic enzymes. Mupirocin biosynthesis is carried out by a combination of type I multifunctional polyketide synthases and tailoring enzymes encoded in a 75 kb gene cluster. Chemical synthesis has also been achieved. This knowledge should allow the synthesis of new and modified antibiotics for the future.
Collapse
|